Literature DB >> 15603217

Sunlight is an important causative factor of recurrent herpes simplex.

Masamitsu Ichihashi1, Hiroshi Nagai, Kayoko Matsunaga.   

Abstract

To evaluate the role of exposure to solar UV radiation (UVR) in primary and recurrent herpes simplex virus 1 (HSV-1) infections, we investigated the self-reported cause of infection among diagnosed patients in Hyogo Prefecture, Japan. Among 4295 infected patients, 3678 had HSV-1, and 2656 of those patients (72.2%) had a recurrent flare-up. Fatigue was the most commonly reported cause of a flare-up among all patients, followed by the common cold and sun exposure. Sun-induced HSV-1 flare-up was reported by 10.4% of the total study population. However, this increased to 19.7% among patients diagnosed in July and August, to 28% among patients younger than 30 years diagnosed in July and August, and to 40% among patients younger than 30 years diagnosed in July and August with a recurrent infection. These results suggest the important role of solar UVR in the development of recurrent HSV-1, possibly due to UVR-induced immunosuppression or direct reactivation of HSV-1 in the neural ganglia.

Entities:  

Mesh:

Year:  2004        PMID: 15603217

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  13 in total

1.  HSV-1 clinical isolates with unique in vivo and in vitro phenotypes and insight into genomic differences.

Authors:  Robert J Danaher; Derrick E Fouts; Agnes P Chan; Yongwook Choi; Jessica DePew; Jamison M McCorrison; Karen E Nelson; Chunmei Wang; Craig S Miller
Journal:  J Neurovirol       Date:  2016-10-13       Impact factor: 2.643

Review 2.  Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.

Authors:  Mark L Hanke; Tammy Kielian
Journal:  Clin Sci (Lond)       Date:  2011-11       Impact factor: 6.124

Review 3.  Are there differences in immune responses following delivery of vaccines through acutely or chronically sun-exposed compared with sun-unexposed skin?

Authors:  Prue H Hart; Mary Norval
Journal:  Immunology       Date:  2019-11-06       Impact factor: 7.397

4.  DNA damage promotes herpes simplex virus-1 protein expression in a neuroblastoma cell line.

Authors:  Ketna Volcy; Nigel W Fraser
Journal:  J Neurovirol       Date:  2013-01-26       Impact factor: 2.643

5.  17-beta estradiol promotion of herpes simplex virus type 1 reactivation is estrogen receptor dependent.

Authors:  Rodolfo D Vicetti Miguel; Brian S Sheridan; Stephen A K Harvey; Robert S Schreiner; Robert L Hendricks; Thomas L Cherpes
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 6.  Herpes Simplex Virus Latency: The DNA Repair-Centered Pathway.

Authors:  Jay C Brown
Journal:  Adv Virol       Date:  2017-02-01

7.  Risk factors for herpes simplex virus type-1 infection and reactivation: Cross-sectional studies among EPIC-Norfolk participants.

Authors:  Harriet Forbes; Ben Warne; Lars Doelken; Nicole Brenner; Tim Waterboer; Robert Luben; Nicholas J Wareham; Charlotte Warren-Gash; Effrossyni Gkrania-Klotsas
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

8.  Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma.

Authors:  Ola Forslund; Thomas Iftner; Kristin Andersson; Bernt Lindelof; Eva Hradil; Peter Nordin; Bo Stenquist; Reinhard Kirnbauer; Joakim Dillner; Ethel-Michele de Villiers
Journal:  J Infect Dis       Date:  2007-08-06       Impact factor: 5.226

9.  An unusual presentation of herpes simplex virus type 1 infection in a child.

Authors:  Hale Sakalli; Hilal Erinanc; Recep Dursun; Esra Baskin
Journal:  Case Rep Dermatol       Date:  2013-02-24

Review 10.  Traditional Chinese Medicine as a Potential Source for HSV-1 Therapy by Acting on Virus or the Susceptibility of Host.

Authors:  Wen Li; Xiao-Hua Wang; Zhuo Luo; Li-Fang Liu; Chang Yan; Chang-Yu Yan; Guo-Dong Chen; Hao Gao; Wen-Jun Duan; Hiroshi Kurihara; Yi-Fang Li; Rong-Rong He
Journal:  Int J Mol Sci       Date:  2018-10-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.